{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:52:30Z","timestamp":1790218350541,"version":"4.1.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:00:00Z","timestamp":1525737600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31470245"],"award-info":[{"award-number":["31470245"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003820","name":"Hubei Provincial Population and Family Planning Commission","doi-asserted-by":"publisher","award":["WJ2015Q03, WJ2017F075"],"award-info":[{"award-number":["WJ2015Q03, WJ2017F075"]}],"id":[{"id":"10.13039\/501100003820","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012554","name":"Educational Commission of Hubei Province","doi-asserted-by":"publisher","award":["T201713"],"award-info":[{"award-number":["T201713"]}],"id":[{"id":"10.13039\/100012554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2015CFA030"],"award-info":[{"award-number":["2015CFA030"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01003","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:32:29Z","timestamp":1525739549000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":66,"title":["Protection Against Helicobacter pylori Infection in BALB\/c Mouse Model by Oral Administration of Multivalent Epitope-Based Vaccine of Cholera Toxin B Subunit-HUUC"],"prefix":"10.3389","volume":"9","author":[{"given":"Xing","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longrui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1177\/2050640615580889","article-title":"The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-analysis","volume":"3","author":"Rokkas","year":"2015","journal-title":"United European Gastroenterol J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1053\/j.gastro.2016.01.028","article-title":"Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis","volume":"150","author":"Lee","year":"2016","journal-title":"Gastroenterology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"44935","DOI":"10.1038\/srep44935","article-title":"Alterations in gastric microbiota after H. pylori eradication and in different histological stages of gastric carcinogenesis","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"key":"B4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrgastro.2017.57","article-title":"Helicobacter pylori infection and antibiotic resistance: a WHO high priority?","volume":"14","author":"Dang","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12396","article-title":"Usefulness of detection of clarithromycin-resistant Helicobacter pylori from fecal specimens for young adults treated with eradication therapy","volume":"22","author":"Osaki","year":"2017","journal-title":"Helicobacter"},{"key":"B6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fcimb.2016.00159","article-title":"Adhesion and invasion of gastric mucosa epithelial cells by Helicobacter pylori","volume":"6","author":"Huang","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"16189","DOI":"10.1038\/nmicrobiol.2016.189","article-title":"Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs","volume":"2","author":"Javaheri","year":"2016","journal-title":"Nat Microbiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrgastro.2011.1","article-title":"Vaccinating against Helicobacter pylori infection","volume":"8","author":"Czinn","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1006\/mpat.2001.0466","article-title":"HpaA shows variable surface localization but the gene expression is similar in different Helicobacter pylori strains","volume":"31","author":"Lundstrom","year":"2001","journal-title":"Microb Pathog"},{"key":"B10","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1128\/IAI.74.2.920-926.2006","article-title":"HpaA is essential for Helicobacter pylori colonization in mice","volume":"74","author":"Carlsohn","year":"2006","journal-title":"Infect Immun"},{"key":"B11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1574-695X.2006.00206.x","article-title":"Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background","volume":"50","author":"Sutton","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.vaccine.2010.11.088","article-title":"A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori","volume":"29","author":"Flach","year":"2011","journal-title":"Vaccine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature11684","article-title":"Structure of the proton-gated urea channel from the gastric pathogen Helicobacter pylori","volume":"493","author":"Strugatsky","year":"2013","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1038\/ncomms3900","article-title":"Mechanisms of molecular transport through the urea channel of Helicobacter pylori","volume":"4","author":"McNulty","year":"2013","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1128\/IAI.66.9.4340-4346.1998","article-title":"Immunization against natural Helicobacter pylori infection in nonhuman primates","volume":"66","author":"Dubois","year":"1998","journal-title":"Infect Immun"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1016\/S0264-410X(01)00119-0","article-title":"Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice","volume":"19","author":"Lee","year":"2001","journal-title":"Vaccine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"6320","DOI":"10.1128\/IAI.71.11.6320-6328.2003","article-title":"Autodisplay efficacious surface exposure of antigenic UreA fragments from Helicobacter pylori in Salmonella vaccine strains","volume":"71","author":"Rizos","year":"2003","journal-title":"Infect Immun"},{"key":"B18","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0016-5085(99)70063-6","article-title":"Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults","volume":"116","author":"Michetti","year":"1999","journal-title":"Gastroenterology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0264-410X(97)00153-9","article-title":"Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant","volume":"16","author":"Marchetti","year":"1998","journal-title":"Vaccine"},{"key":"B20","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.1016\/j.vaccine.2011.06.099","article-title":"Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3389\/fimmu.2013.00328","article-title":"Helicobacter pylori CagA: from pathogenic mechanisms to its use as an anti-cancer vaccine","volume":"4","author":"Stein","year":"2013","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1053\/j.gastro.2008.05.054","article-title":"Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study","volume":"135","author":"Malfertheiner","year":"2008","journal-title":"Gastroenterology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3389\/fcimb.2017.00349","article-title":"Oral immunization with a multivalent epitope-based vaccine, based on NAP, urease, HSP60, and HpaA, provides therapeutic effect on H. pylori infection in Mongolian gerbils","volume":"7","author":"Guo","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3390\/toxins7030974","article-title":"Cholera toxin B: one subunit with many pharmaceutical applications","volume":"7","author":"Baldauf","year":"2015","journal-title":"Toxins (Basel)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3390\/toxins9120379","article-title":"Therapeutic potential of cholera toxin B subunit for the treatment of inflammatory diseases of the mucosa","volume":"9","author":"Royal","year":"2017","journal-title":"Toxins (Basel)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e12428","DOI":"10.1111\/hel.12428","article-title":"Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in mongolian gerbils","volume":"22","author":"Guo","year":"2017","journal-title":"Helicobacter"},{"key":"B27","doi-asserted-by":"publisher","first-page":"ftv026","DOI":"10.1093\/femspd\/ftv026","article-title":"Protection against Helicobacter pylori infection in BALB\/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB","volume":"73","author":"Yang","year":"2015","journal-title":"Pathog Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.1016\/j.vaccine.2009.05.009","article-title":"Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB\/c mice model","volume":"27","author":"Zhou","year":"2009","journal-title":"Vaccine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1586\/erv.13.20","article-title":"Why can\u2019t we make an effective vaccine against Helicobacter pylori?","volume":"12","author":"Sutton","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"B30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/hel.12336","article-title":"Inflammation, immunity, and vaccines for Helicobacter pylori infection","volume":"21","author":"Velin","year":"2016","journal-title":"Helicobacter"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1016\/j.vaccine.2006.12.026","article-title":"Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses","volume":"25","author":"Nystr\u00f6m","year":"2007","journal-title":"Vaccine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3880","DOI":"10.1128\/IAI.01424-12","article-title":"Contribution of secretory antibodies to intestinal mucosal immunity against Helicobacter pylori","volume":"81","author":"Gorrell","year":"2013","journal-title":"Infect Immun"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S0140-6736(15)60310-5","article-title":"Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"386","author":"Zeng","year":"2015","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"6597","DOI":"10.1128\/IAI.69.11.6597-6603.2001","article-title":"Identification of an antigenic epitope in Helicobacter pylori urease that induces neutralizing antibody production","volume":"69","author":"Hirota","year":"2001","journal-title":"Infect Immun"},{"key":"B35","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/bit.20060","article-title":"Epitope mapping and features of the epitope for monoclonal antibodies inhibiting enzymatic activity of Helicobacter pylori urease","volume":"86","author":"Fujii","year":"2004","journal-title":"Biotechnol Bioeng"},{"key":"B36","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.imlet.2005.10.016","article-title":"A catalytic antibody heavy chain HpU-2 degrading its epitope peptide and H. pylori urease","volume":"103","author":"Hifumi","year":"2006","journal-title":"Immunol Lett"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00253-011-3726-0","article-title":"Immunological features and the ability of inhibitory effects on enzymatic activity of an epitope vaccine composed of cholera toxin B subunit and B cell epitope from Helicobacter pylori urease A subunit","volume":"93","author":"Guo","year":"2012","journal-title":"Appl Microbiol Biotechnol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1007\/s00253-012-4486-1","article-title":"Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB\/c mice model","volume":"97","author":"Guo","year":"2013","journal-title":"Appl Microbiol Biotechnol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1084\/jem.188.12.2277","article-title":"Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses","volume":"188","author":"Ermak","year":"1998","journal-title":"J Exp Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0016-5085(00)70213-7","article-title":"A predominant Th1 type of immune response is induced early during acute Helicobacter pylori infection in rhesus macaques","volume":"118","author":"Mattapallil","year":"2000","journal-title":"Gastroenterology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.4049\/jimmunol.0901115","article-title":"Helicobacter pylori-induced Th17 responses modulate Th1\u2009cell responses, benefit bacterial growth, and contribute to pathology in mice","volume":"184","author":"Shi","year":"2010","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.vaccine.2012.10.091","article-title":"Systemic immunization with an epitope-based vaccine elicits a Th1-biased response and provides protection against Helicobacter pylori in mice","volume":"31","author":"Li","year":"2012","journal-title":"Vaccine"},{"key":"B43","doi-asserted-by":"publisher","first-page":"14793","DOI":"10.1038\/srep14793","article-title":"Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB\/c mice","volume":"5","author":"Li","year":"2015","journal-title":"Sci Rep"},{"key":"B44","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1586\/egh.10.71","article-title":"Helicobacter pylori and its effect on innate and adaptive immunity: new insights and vaccination strategies","volume":"4","author":"Sundquist","year":"2010","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/hel.12156","article-title":"Immunity, inflammation, and vaccines for Helicobacter pylori","volume":"19","author":"D\u2019elios","year":"2014","journal-title":"Helicobacter"},{"key":"B46","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.micpath.2018.01.040","article-title":"T cell subsets play an important role in the determination of the clinical outcome of Helicobacter pylori infection","volume":"116","author":"Jafarzadeh","year":"2018","journal-title":"Microb Pathog"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.01003\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T13:02:52Z","timestamp":1604235772000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.01003\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":46,"alternative-id":["10.3389\/fimmu.2018.01003"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01003","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,8]]},"article-number":"1003"}}